Association of the Maternal MTHFR C677T Polymorphism with Susceptibility to Neural Tube Defects in Offsprings: Evidence from 25 Case-Control Studies

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Yan, Lifeng ^a,b   Zhao, Lin ^a   Long, Yan ^c   Zou, Peng ^a   Ji, Guixiang ^d   Gu, Aihua ^a,b   Zhao, Peng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

^d NANJING INSTITUTE OF ENVIRONMENTAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOSINE; THYMINE;

ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; EMBASE; ETHNICITY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MEDLINE; MTHFR GENE; NEURAL TUBE DEFECT; PROGENY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MODELS, GENETIC; NEURAL TUBE DEFECTS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 84867038698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041689     Document Type: Article

References (57)

1. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ, (2001) Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood) 226: 243-270.
2. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A, (1998) Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157: 487-492.
3. Hosseini M, Houshmand M, Ebrahimi A, (2011) MTHFR polymorphisms and breast cancer risk. Arch Med Sci 7: 134-137.
4. Zeisel SH, (2009) Importance of methyl donors during reproduction. Am J Clin Nutr 89: 673S-677S.
5. Speer MC, Worley G, Mackey JF, Melvin E, Oakes WJ, et al. (1997) The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. The NTD Collaborative Group. Neurogenetics 1: 149-150.
6. Marini NJ, Hoffmann TJ, Lammer EJ, Hardin J, Lazaruk K, et al. (2011) A genetic signature of spina bifida risk from pathway-informed comprehensive gene-variant analysis. PLoS One 6: e28408.
7. Das PM, Singal R, (2004) DNA methylation and cancer. J Clin Oncol 22: 4632-4642.
8. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE, (2001) Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22: 195-201.
9. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, et al. (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7: 195-200.
10. Sameer AS, Shah ZA, Nissar S, Mudassar S, Siddiqi MA, (2011) Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population. Genet Mol Res 10: 1200-1210.
11. Sharp L, Little J, (2004) Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 159: 423-443.
12. Kang SS, Wong PW, (1996) Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 119: 135-138.
13. van der Put NM, Blom HJ, (2000) Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol 92: 57-61.
14. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
15. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
16. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
17. Arbour L, Christensen B, Delormier T, Platt R, Gilfix B, et al. (2002) Spina bifida, folate metabolism, and dietary folate intake in a Northern Canadian aboriginal population. Int J Circumpolar Health 61: 341-351.
18. Candito M, Rivet R, Herbeth B, Boisson C, Rudigoz RC, et al. (2008) Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case-control study. Am J Med Genet A 146A: 1128-1133.
19. Ceyhan ST, Beyan C, Bahce M, Baser I, Kaptan K, et al. (2008) Thrombophilia-associated gene mutations in women with pregnancies complicated by fetal neural tube defects. Int J Gynaecol Obstet 101: 188-189.
20. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, et al. (1999) Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84: 151-157.
21. Dalal A, Pradhan M, Tiwari D, Behari S, Singh U, et al. (2007) MTHFR 677C->T and 1298A->C polymorphisms: evaluation of maternal genotypic risk and association with level of neural tube defect. Gynecol Obstet Invest 63: 146-150.
22. Deb R, Arora J, Meitei SY, Gupta S, Verma V, et al. (2011) Folate supplementation, MTHFR gene polymorphism and neural tube defects: a community based case control study in North India. Metab Brain Dis 26: 241-246.
23. Felix TM, Leistner S, Giugliani R, (2004) Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 70: 459-463.
24. Godbole K, Gayathri P, Ghule S, Sasirekha BV, Kanitkar-Damle A, et al. (2011) Maternal one-carbon metabolism, MTHFR and TCN2 genotypes and neural tube defects in India. Birth Defects Res A Clin Mol Teratol 91: 848-856.
25. Houcher B, Bourouba R, Djabi F, Yilmaz E, Egin Y, et al. (2009) Polymorphisms of 5,10-methylenetetrahydrofolate reductase and cystathionine beta-synthase genes as a risk factor for neural tube defects in Setif, Algeria. Pediatr Neurosurg 45: 472-477.
26. Lacasana M, Blanco-Munoz J, Borja-Aburto VH, Aguilar-Garduno C, Rodriguez-Barranco M, et al. (2012) Effect on risk of anencephaly of gene-nutrient interactions between methylenetetrahydrofolate reductase C677T polymorphism and maternal folate, vitamin B12 and homocysteine profile. Public Health Nutr: 1-10.
27. Li K, Zheng D, Xue Y, Sun Y, Chen L, et al. (2000) [The common C677T polymorphism in the methylenetetrahydrofolate reductase gene is associated with neural tube defects and preeclampsia]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 17: 76-78.
28. Lucock M, Daskalakis I, Briggs D, Yates Z, Levene M, (2000) Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c-> t methylenetetrahydrofolate reductase and 2756a-> g methionine synthase genotypes. Mol Genet Metab 70: 27-44.
29. Martinez de Villarreal LE, Delgado-Enciso I, Valdez-Leal R, Ortiz-Lopez R, Rojas-Martinez A, et al. (2001) Folate levels and N(5), N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Med Res 32: 277-282.
30. Molloy AM, Mills JL, Kirke PN, Ramsbottom D, McPartlin JM, et al. (1998) Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 78: 155-159.
31. Munoz JB, Lacasana M, Cavazos RG, Borja-Aburto VH, Galaviz-Hernandez C, et al. (2007) Methylenetetrahydrofolate reductase gene polymorphisms and the risk of anencephaly in Mexico. Mol Hum Reprod 13: 419-424.
32. Naushad SM, Devi AR, (2010) Role of parental folate pathway single nucleotide polymorphisms in altering the susceptibility to neural tube defects in South India. J Perinat Med 38: 63-69.
33. Parle-McDermott A, Mills JL, Kirke PN, O'Leary VB, Swanson DA, et al. (2003) Analysis of the MTHFR 1298A->C and 677C->T polymorphisms as risk factors for neural tube defects. J Hum Genet 48: 190-193.
34. Perez AB, D'Almeida V, Vergani N, de Oliveira AC, de Lima FT, et al. (2003) Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet A 119A: 20-25.
35. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, et al. (2004) Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41: 256-260.
36. Relton CL, Wilding CS, Laffling AJ, Jonas PA, Burgess T, et al. (2004) Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 81: 273-281.
37. Shang Y, Zhao H, Niu B, Li WI, Zhou R, et al. (2008) Correlation of polymorphism of MTHFRs and RFC-1 genes with neural tube defects in China. Birth Defects Res A Clin Mol Teratol 82: 3-7.
38. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, et al. (1999) The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64: 1045-1055.
39. Ubbink JB, Christianson A, Bester MJ, Van Allen MI, Venter PA, et al. (1999) Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metabolism 48: 269-274.
40. Wang F, Yang YF, Li PZ, (2008) [A case-control study on the risk factors of neural tube defects in Shanxi province]. Zhonghua Liu Xing Bing Xue Za Zhi 29: 771-774.
41. Yu J, Chen B, Zhang G, Fu S, Li P, (2000) The 677 C->T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in five Chinese ethnic groups. Hum Hered 50: 268-270.
42. Morrison K, Papapetrou C, Hol FA, Mariman EC, Lynch SA, et al. (1998) Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62: 379-396.
43. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, et al. (1997) Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349: 1591-1593.
44. Rozen R, (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78: 523-526.
45. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, et al. (1999) A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8: 825-829.
46. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, et al. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102.
47. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, et al. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1071.
48. Botto LD, Yang Q, (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151: 862-877.
49. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, et al. (2002) Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107: 162-168.
50. Han D, Shen C, Meng X, Bai J, Chen F, et al. (2012) Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies. Mol Biol Rep 39: 805-816.
51. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E, (1999) Association of the 677C->T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects. J Child Neurol 14: 159-161.
52. Robien K, Ulrich CM, (2003) 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157: 571-582.
53. Botto LD, Mastroiacovo P, (1998) Exploring gene-gene interactions in the etiology of neural tube defects. Clin Genet 53: 456-459.
54. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJ, Eskes TK, et al. (1996) Decreased methylene tetrahydrofolate reductase activity due to the 677C->T mutation in families with spina bifida offspring. J Mol Med (Berl) 74: 691-694.
55. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, et al. (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47: 319-324.
56. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, et al. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-1051.
57. O'Leary VB, Mills JL, Parle-McDermott A, Pangilinan F, Molloy AM, et al. (2005) Screening for new MTHFR polymorphisms and NTD risk. Am J Med Genet A 138A: 99-106.